Citation Information :
Srinivasan R, Dey P, Prasad G, Rajwanshi A, Gupta N, Siwatch S, Rai B, Madan R, Chowdhary A, Gude G, Jain V, Rohilla M. Fertility Sparing Management in Carcinoma Endometrium. J Postgrad Med Edu Res 2017; 51 (3):152-153.
Prognostic factors for uterine cancers in reproductive age women. Obstet Gynecol 2007 Mar;109(3):655-662.
Endometrial cancer treatment Physician Data Query (PDQ) 2015; http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/healthprofessional (last accessed 1 April 2015).
Endometrial cancer in women 40 years old or younger. Gynecol Oncol 2001 Nov;83(2):388-393.
Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998 Mar;91(3):349-354.
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol 2011 Mar;22(3):643-649.
Int J Gynecol Cancer 2015 Sep;25(7):1258-1265.
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 2009 Apr;113(1):105-108.
Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999 Sep;212(3):711-718.
Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer. Gynecol Oncol 2013 Sep;130(3):470-473.
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol 2012 Oct;207(4):266.e1-266.e12.
